Abstract:External exposure concentrations were conventionally employed usedto quantify toxicological effects of chemicals in their risk assessment.However, internal concentrations are more suitable for understandingthe toxicological effects and conducting risk assessment. It is necessaryfor accurate risk assessment of chemicals to predict the internalexposure of chemicals from the external exposure, and to know distributionof chemicals in different target tissues/organs (e.g. liver, kidney)of organisms. Experimental determination can hardly get high-throughputacquisition of target concentrations due to analytical limitationsand expensive cost for in vivo animal tests. Alternatively,physiologically based toxicokinetics (PBTK) models that can quantitativelypredict absorption, distribution, metabolism and excretion (ADME)processes of chemicals in biota are particularly useful. PBTK modelscould be used to predict the target concentrations, and to relatethe environmental exposure concentrations with the target concentrations. Development of PBTK models can be divided into five steps. (1)Specify the general model structure. Portal of entry, target organ,lipophilicity and metabolism of chemicals are basic factors that shouldbe considered. (2) Determine the set of ordinary differential equationsrepresenting the ADME processes of chemicals by the organism. Allof these equations are mass balance equations. (3) Define model parameters,including physiological parameters, partition coefficients, biochemicalrate constants and environment parameters. (4) Solve the ordinarydifferential equations with proper software. (5) Validate the model.Simulation results should be compared with corresponding experimentaldata to evaluate whether the model is accurate enough. Sensitivity,uncertainty and variability analysis should be performed to furtheroptimize the model. Originating as a tool for serving pharmaceutical industry, PBTKmodels are now used in risk assessment of chemicals. PBTK models canalso relate the in vivo toxicity thresholds withthe in vitro toxicity thresholds. The invitro-in vivo extrapolation can facilitate the utilizationof the vast volume of high-throughput in vitro data.Traditional in vivo tests only focus on a limitednumber of the diverse species residing within an ecosystem. PBTK modelscan provide a promising cross-species solution by establishing physiologicallyrelevant models for various species. Besides, classical indicatorsfor hazard assessment such as bioconcentration factors could be re-evaluatedby PBTK models with upgraded accuracy and details. Furthermore, itis possible to simulate the risk of chemicals that exerted on organismsover the entire lifetime of organisms with a sequence of PBTK modelsrepresenting different developmental stages of the species. The combinationof PBTK models and toxicodynamics (TD) models, i.e. PBTK/TD models,can further realize the simulation of the dynamic distribution ofxenobiotics as well as the effects simultaneously. The power of PBTK models intended for ecological risk assessmentof chemicals is yet to be fully exploited. Current PBTK models mainlyapply to chemicals of neutral states. However, the molecular structuresof many organic pollutants have carboxylic, phenolic groups, etc.Thus, these compounds can ionize under environmental pH conditions.A compound with different ionized states could possess different intakepathways. Thus, certain modifications of the mathematical form ofthe PBTK models are necessary. Another major obstacle is that thesophisticated parameters of PBTK models cannot be easily collected.Therefore, schemes for a high-throughput acquisition of the relevantparameters (e.g. quantitative structure-activity relationship models)would be highly useful. Furthermore, PBTK models should be extendedto more species of ecological importance.

Development of Physiologically Based Toxicokinetic Models for 3-Monochloropropane-1,2-diol and Glycidol.

Metabolomics-based Biomarker Analysis of Dihydroxypropyl Mercapturic Acid Isomers from 3-Monochloropropane-1,2-diol and Glycidol for Evaluation of Toxicokinetics in Rats and Daily Internal Exposure in Humans

Urinary Non-Targeted Toxicokinetics and Metabolic Fingerprinting of Exposure to 3-Monochloropropane-1,2-diol and Glycidol from Refined Edible Oils

The Construction and Application of Physiologically Based Toxicokinetic Models for Acrylamide, Glycidamide and Their Biomarkers in Rats and Humans.

Toxicokinetics and Metabolism of 3-Monochloropropane 1,2-Diol Dipalmitate in Sprague Dawley Rats.

Bayesian analysis of physiologically based toxicokinetic (PBTK) modeling for pentachlorophenol exposure in pregnant women

Physiologically Based Toxicokinetic Modelling of Tri(2-chloroethyl) Phosphate (TCEP) in Mice Accounting for Multiple Exposure Routes

Application of physiologically based toxicokinetics models in risk assessment of chemicals

Physiologically Based Pharmacokinetic Modeling for Chlorinated Paraffins in Rats and Humans: Importance of Biliary Excretion.

Absorption, Distribution, Metabolism and Excretion of 3-MCPD 1-Monopalmitate after Oral Administration in Rats.

Potential Biomarkers for Early Detection of 3-MCPD Dipalmitate Exposure in Sprague-Dawley Rats

Predicting nonlinear relationships between external and internal concentrations with physiologically based pharmacokinetic modeling

Physiologically-based Toxicokinetic Model for the Prediction of Perchlorate Distribution and Its Application.

Integration of Metabolomics and Transcriptomics Reveals Short-Chain Chlorinated Paraffin-Induced Hepatotoxicity in Male Sprague-Dawley Rat.

Proteomic Analyses of 3-Monochloropropanediol 1-Monooleate and 1-Monostearate Induced Testicular Toxicity in a 90 Day Sprague-Dawley Rats' Study.

Using available in vitro metabolite identification and time course kinetics for β-chloroprene and its metabolite, (1-chloroethenyl) oxirane, to include reactive oxidative metabolites and glutathione depletion in a PBPK model for β-chloroprene

Physiologically-based toxicokinetic modeling of human dermal exposure to diethyl phthalate: Application to health risk assessment

The Application of a Physiologically Based Toxicokinetic Model in Health Risk Assessment

Enhanced prediction of internal concentrations of phenolic endocrine disrupting chemicals and their metabolites in fish by a physiologically based toxicokinetic incorporating metabolism (PBTK-MT) model

Study on Physiologically based Pharmacokinetic Model of Vinyl chloride metabolism

A physiologically based pharmacokinetic model of diethyl phthalates in humans